- Home
- AESI vs XNCR Comparison
AESI vs XNCR Comparison
Compare AESI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AESI | XNCR |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | AESI | XNCR |
|---|---|---|
| Price | $14.58 | $24.94 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 6 | 9 |
| Target Price | $13.17 | ★ $22.33 |
| AVG Volume (30 Days) | ★ 2.9M | 1.3M |
| Earning Date | 05-04-2026 | 05-08-2026 |
| Dividend Yield | ★ 2.91% | N/A |
| EPS Growth | N/A | ★ 65.36 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,095,310,000.00 | $125,576,000.00 |
| Revenue This Year | $2.71 | N/A |
| Revenue Next Year | $17.78 | $4.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.73 | ★ 13.65 |
| 52 Week Low | $7.64 | $8.29 |
| 52 Week High | $20.13 | $30.61 |
Technical Indicators
Market Signals| Indicator | AESI | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 66.39 | 51.36 |
| Support Level | $13.50 | $11.20 |
| Resistance Level | $15.36 | $30.61 |
| Average True Range (ATR) | 0.70 | 1.62 |
| MACD | 0.25 | -0.60 |
| Stochastic Oscillator | 99.63 | 3.02 |
Price Performance
Historical ComparisonAbout AESI Atlas Energy Solutions Inc.
Atlas Energy Solutions Inc is a provider of proppant and logistics services to the oil and natural gas industry within the Permian Basin of West Texas and New Mexico, the active oil and natural gas basin in North America. Proppant is necessary to facilitate the recovery of hydrocarbons from oil and natural gas wells. One hundred percent of its sand reserves are located in Winkler and Ward Counties, Texas, within the Permian Basin, and its operations consist of proppant production and processing facilities, including two facilities near Kermit, Texas, and a third facility near Monahans, Texas.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.